
Opinion|Videos|March 18, 2025
Evolution of Oncology Pharmacy Practice in mCRC
Experts discuss how the role of oncology pharmacists in managing metastatic colorectal cancer (mCRC) has evolved, particularly in enabling medication adjustments, refills, and prescribing supportive care medications, and explore the impact of this expanded role on patient outcomes and how pharmacists can leverage medication knowledge to optimize treatment and patient care further.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How has the role of oncology pharmacists in managing mCRC evolved, particularly in enabling medication adjustments, refills, and prescribing supportive care medications?
- What impact has this expanded role had on patient outcomes?
- In what ways can pharmacists leverage medication knowledge to optimize treatment and patient care for mCRC further?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
3
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
4
New TROP2-Targeted ADC Shows Promise in TNBC: Erika Hamilton, MD
5












































